Identification of 9 novel FBN1 mutations in German patients with Marfan syndrome.

Alice Kamal Abd El Aleem, M. Karck, A. Haverich, J. Schmidtke, M. Arslan-Kirchner

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We report 9 new mutations in German patients presenting with classical Marfan syndrome. All mutations occur in exons with calcium-binding (cb) epidermal growth factor-like (EGF) domains. Five mutations are missense involving exons 12, 27, 30, 44, and 52 with the resultant substitution of cysteine by phenylalanine (C504F), cysteine by tyrosine (C1129Y), tyrosine by cysteine (Y1261C), cysteine by serine (C1833S), and cysteine by tyrosine (C2142Y), respectively. The other four mutations are single base deletions in exons 39, 43, 48, and 58, at nucleotide A4826, C5311, T6018, and A7291, respectively, each resulting in frameshift with premature termination. Four mutations were detected in sporadic cases and are likely to be de novo.

Original languageEnglish
Pages (from-to)181
Number of pages1
JournalHuman Mutation
Volume14
Issue number2
Publication statusPublished - 19 Aug 1999
Externally publishedYes

Fingerprint

Marfan Syndrome
Cysteine
Mutation
Tyrosine
Exons
Missense Mutation
Phenylalanine
Epidermal Growth Factor
Serine
Nucleotides
Calcium

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Kamal Abd El Aleem, A., Karck, M., Haverich, A., Schmidtke, J., & Arslan-Kirchner, M. (1999). Identification of 9 novel FBN1 mutations in German patients with Marfan syndrome. Human Mutation, 14(2), 181.

Identification of 9 novel FBN1 mutations in German patients with Marfan syndrome. / Kamal Abd El Aleem, Alice; Karck, M.; Haverich, A.; Schmidtke, J.; Arslan-Kirchner, M.

In: Human Mutation, Vol. 14, No. 2, 19.08.1999, p. 181.

Research output: Contribution to journalArticle

Kamal Abd El Aleem, A, Karck, M, Haverich, A, Schmidtke, J & Arslan-Kirchner, M 1999, 'Identification of 9 novel FBN1 mutations in German patients with Marfan syndrome.', Human Mutation, vol. 14, no. 2, pp. 181.
Kamal Abd El Aleem A, Karck M, Haverich A, Schmidtke J, Arslan-Kirchner M. Identification of 9 novel FBN1 mutations in German patients with Marfan syndrome. Human Mutation. 1999 Aug 19;14(2):181.
Kamal Abd El Aleem, Alice ; Karck, M. ; Haverich, A. ; Schmidtke, J. ; Arslan-Kirchner, M. / Identification of 9 novel FBN1 mutations in German patients with Marfan syndrome. In: Human Mutation. 1999 ; Vol. 14, No. 2. pp. 181.
@article{d5d1c2b7f0474247a5fb52cb766ee92c,
title = "Identification of 9 novel FBN1 mutations in German patients with Marfan syndrome.",
abstract = "We report 9 new mutations in German patients presenting with classical Marfan syndrome. All mutations occur in exons with calcium-binding (cb) epidermal growth factor-like (EGF) domains. Five mutations are missense involving exons 12, 27, 30, 44, and 52 with the resultant substitution of cysteine by phenylalanine (C504F), cysteine by tyrosine (C1129Y), tyrosine by cysteine (Y1261C), cysteine by serine (C1833S), and cysteine by tyrosine (C2142Y), respectively. The other four mutations are single base deletions in exons 39, 43, 48, and 58, at nucleotide A4826, C5311, T6018, and A7291, respectively, each resulting in frameshift with premature termination. Four mutations were detected in sporadic cases and are likely to be de novo.",
author = "{Kamal Abd El Aleem}, Alice and M. Karck and A. Haverich and J. Schmidtke and M. Arslan-Kirchner",
year = "1999",
month = "8",
day = "19",
language = "English",
volume = "14",
pages = "181",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Identification of 9 novel FBN1 mutations in German patients with Marfan syndrome.

AU - Kamal Abd El Aleem, Alice

AU - Karck, M.

AU - Haverich, A.

AU - Schmidtke, J.

AU - Arslan-Kirchner, M.

PY - 1999/8/19

Y1 - 1999/8/19

N2 - We report 9 new mutations in German patients presenting with classical Marfan syndrome. All mutations occur in exons with calcium-binding (cb) epidermal growth factor-like (EGF) domains. Five mutations are missense involving exons 12, 27, 30, 44, and 52 with the resultant substitution of cysteine by phenylalanine (C504F), cysteine by tyrosine (C1129Y), tyrosine by cysteine (Y1261C), cysteine by serine (C1833S), and cysteine by tyrosine (C2142Y), respectively. The other four mutations are single base deletions in exons 39, 43, 48, and 58, at nucleotide A4826, C5311, T6018, and A7291, respectively, each resulting in frameshift with premature termination. Four mutations were detected in sporadic cases and are likely to be de novo.

AB - We report 9 new mutations in German patients presenting with classical Marfan syndrome. All mutations occur in exons with calcium-binding (cb) epidermal growth factor-like (EGF) domains. Five mutations are missense involving exons 12, 27, 30, 44, and 52 with the resultant substitution of cysteine by phenylalanine (C504F), cysteine by tyrosine (C1129Y), tyrosine by cysteine (Y1261C), cysteine by serine (C1833S), and cysteine by tyrosine (C2142Y), respectively. The other four mutations are single base deletions in exons 39, 43, 48, and 58, at nucleotide A4826, C5311, T6018, and A7291, respectively, each resulting in frameshift with premature termination. Four mutations were detected in sporadic cases and are likely to be de novo.

UR - http://www.scopus.com/inward/record.url?scp=18844467335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18844467335&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 181

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 2

ER -